BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 34463456)

  • 1. [Anaplastic astrocytoma and anaplastic oligodendroglioma of the brain: current state of the problem].
    Belyaev AY; Usachev DY; Pronin IN; Shults EI; Batalov AI
    Zh Vopr Neirokhir Im N N Burdenko; 2021; 85(4):96-102. PubMed ID: 34463456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging of hypoxic lesions in patients with gliomas by using positron emission tomography with 1-(2-[18F] fluoro-1-[hydroxymethyl]ethoxy)methyl-2-nitroimidazole, a new 18F-labeled 2-nitroimidazole analog.
    Shibahara I; Kumabe T; Kanamori M; Saito R; Sonoda Y; Watanabe M; Iwata R; Higano S; Takanami K; Takai Y; Tominaga T
    J Neurosurg; 2010 Aug; 113(2):358-68. PubMed ID: 19895196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-invasive diagnosis of brain gliomas by histological type using neuroradiomics in standardized regions of interest: towards digital biopsy.
    Danilov GV; Shevchenko AM; Konakova TA; Pogosbekyan EL; Shugai SV; Tsukanova TV; Zakharova NE; Batalov AI; Agrba SB; Vikhrova NB; Pronin IN
    Zh Vopr Neirokhir Im N N Burdenko; 2023; 87(6):59-66. PubMed ID: 38054228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anaplastic Glioma: Treatment Approaches in the Era of Molecular Diagnostics.
    Ruff MW; Uhm J
    Curr Treat Options Oncol; 2018 Oct; 19(12):61. PubMed ID: 30361986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diffuse Infiltrating Oligodendroglioma and Astrocytoma.
    van den Bent MJ; Smits M; Kros JM; Chang SM
    J Clin Oncol; 2017 Jul; 35(21):2394-2401. PubMed ID: 28640702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T2 mapping of the peritumoral infiltration zone of glioblastoma and anaplastic astrocytoma.
    Auer TA; Kern M; Fehrenbach U; Tanyldizi Y; Misch M; Wiener E
    Neuroradiol J; 2021 Oct; 34(5):392-400. PubMed ID: 33573473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic susceptibility contrast and diffusion MR imaging identify oligodendroglioma as defined by the 2016 WHO classification for brain tumors: histogram analysis approach.
    Latysheva A; Emblem KE; Brandal P; Vik-Mo EO; Pahnke J; Røysland K; Hald JK; Server A
    Neuroradiology; 2019 May; 61(5):545-555. PubMed ID: 30712139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Grade II and III Oligodendroglioma and Astrocytoma.
    van den Bent MJ; Chang SM
    Neurol Clin; 2018 Aug; 36(3):467-484. PubMed ID: 30072066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anaplastic astrocytoma and anaplastic oligodendroglioma occurring 6 years after subtotal resection of a central neurocytoma. Case report.
    Kanamori M; Kumabe T; Watanabe M; Tominaga T
    J Neurosurg; 2007 Jul; 107(1):185-9. PubMed ID: 17639893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorescence-guidance in non-Gadolinium enhancing, but FET-PET positive gliomas.
    Schebesch KM; Brawanski A; Doenitz C; Rosengarth K; Proescholdt M; Riemenschneider MJ; Grosse J; Hellwig D; Höhne J
    Clin Neurol Neurosurg; 2018 Sep; 172():177-182. PubMed ID: 30032095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic impact of the 2016 WHO classification of diffuse gliomas in the French POLA cohort.
    Tabouret E; Nguyen AT; Dehais C; Carpentier C; Ducray F; Idbaih A; Mokhtari K; Jouvet A; Uro-Coste E; Colin C; Chinot O; Loiseau H; Moyal E; Maurage CA; Polivka M; Lechapt-Zalcman E; Desenclos C; Meyronet D; Delattre JY; Figarella-Branger D;
    Acta Neuropathol; 2016 Oct; 132(4):625-34. PubMed ID: 27573687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment updates regarding anaplastic oligodendroglioma and anaplastic oligoastrocytoma.
    Khan KA; Abbasi AN; Ali N
    J Coll Physicians Surg Pak; 2014 Dec; 24(12):935-9. PubMed ID: 25523732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small cell astrocytoma: an aggressive variant that is clinicopathologically and genetically distinct from anaplastic oligodendroglioma.
    Perry A; Aldape KD; George DH; Burger PC
    Cancer; 2004 Nov; 101(10):2318-26. PubMed ID: 15470710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic Performance of [
    Nakajo K; Uda T; Kawashima T; Terakawa Y; Ishibashi K; Tsuyuguchi N; Tanoue Y; Nagahama A; Uda H; Koh S; Sasaki T; Ohata K; Kanemura Y; Goto T
    World Neurosurg; 2021 Apr; 148():e471-e481. PubMed ID: 33444827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 11C-Methionine positron emission tomography for preoperative evaluation of suggestive low-grade gliomas.
    Gumprecht H; Grosu AL; Souvatsoglou M; Dzewas B; Weber WA; Lumenta CB
    Zentralbl Neurochir; 2007 Feb; 68(1):19-23. PubMed ID: 17487804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cerebral gliomas, their appearance in CT and rational therapy].
    Kvícala V
    Cesk Radiol; 1982 Jul; 36(4):219-24. PubMed ID: 6290088
    [No Abstract]   [Full Text] [Related]  

  • 17. Artificial Intelligence-Assisted Classification of Gliomas Using Whole Slide Images.
    Jose L; Liu S; Russo C; Cong C; Song Y; Rodriguez M; Di Ieva A
    Arch Pathol Lab Med; 2023 Aug; 147(8):916-924. PubMed ID: 36445697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrinsic radiation sensitivity may not be the major determinant of the poor clinical outcome of glioblastoma multiforme.
    Taghian A; Ramsay J; Allalunis-Turner J; Budach W; Gioioso D; Pardo F; Okunieff P; Bleehen N; Urtasun R; Suit H
    Int J Radiat Oncol Biol Phys; 1993 Jan; 25(2):243-9. PubMed ID: 8380568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular classification of anaplastic oligodendroglioma using next-generation sequencing: a report of the prospective randomized EORTC Brain Tumor Group 26951 phase III trial.
    Dubbink HJ; Atmodimedjo PN; Kros JM; French PJ; Sanson M; Idbaih A; Wesseling P; Enting R; Spliet W; Tijssen C; Dinjens WN; Gorlia T; van den Bent MJ
    Neuro Oncol; 2016 Mar; 18(3):388-400. PubMed ID: 26354927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas.
    Hartmann C; Hentschel B; Wick W; Capper D; Felsberg J; Simon M; Westphal M; Schackert G; Meyermann R; Pietsch T; Reifenberger G; Weller M; Loeffler M; von Deimling A
    Acta Neuropathol; 2010 Dec; 120(6):707-18. PubMed ID: 21088844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.